One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals Post author: Post published:November 16, 2023 Post category:uncategorized The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients. You Might Also Like Can music therapy be the breakthrough dementia care desperately needs? November 18, 2024 Personalized vitamin D guidelines based on latitude and skin type could tackle deficiencies May 17, 2024 AI tool helps develop the most complete map of the bacterial essential interactome February 23, 2024
Personalized vitamin D guidelines based on latitude and skin type could tackle deficiencies May 17, 2024